Menopausal Hot Flashes Market by Distribution Channel and Geography - Forecast and Analysis 2021-2025

  • Published: Oct 2021
  • Pages: 120
  • SKU: IRTNTR44832
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The menopausal hot flashes market share is expected to increase by USD 2.19 billion from 2021 to 2025, and the market’s growth momentum will accelerate at a CAGR of 3.82%.

This menopausal hot flashes market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by distribution channel (offline and online) and geography (North America, Europe, Asia, and ROW). The menopausal hot flashes market report also offers information on several market vendors, including AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, GlaxoSmithKline Plc, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, and Pfizer Inc. among others.

What will the Menopausal Hot Flashes Market Size be in 2021?

Download the Free Report Sample to Unlock the Menopausal Hot Flashes Market Size for 2021 and Other Important Statistics

 

Menopausal Hot Flashes Market: Key Drivers and Trends

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The change in lifestyle is notably driving the menopausal hot flashes market growth, although factors such as side effects may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the menopausal hot flashes industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

  • One of the key factors driving growth in the menopausal hot flashes market is the change in lifestyle.
  • Women these days are increasingly indulging in adventurous activities and sports, including adventure treks, swimming, running, and working out.
  • The activities have a valuable effect on mood and cardiovascular and bone health but there is very little evidence that suggests that they help in managing vasomotor instability symptoms, including hot flashes and night sweats.
  • The increasing stress levels can lead to hormonal imbalance in women, which, in turn, causes a decline in hormonal levels, leading to early menopause.
  • Menopausal symptoms are a notable trend among younger women who are surgically menopausal, wherein hot flashes are usually more rigorous than in older women, which can last until the natural age for menopause.
  • The rise in disposable income is another factor supporting the menopausal hot flashes market share growth.
  • The per capita disposable income exhibits low volatility in developed countries because of a spike in double-income households.
  • Disposable income is increasing globally, especially at a fast rate in some countries on the Pacific Rim, such as Malaysia, Indonesia, and Vietnam.
  • The increase in disposable income enables consumers to spend more on women's health solutions.
  • Financial opportunities for women in urban areas have resulted in a shift from rural to urban areas.
  • The increase in awareness among people about the availability of solutions for vasomotor symptoms in the market, along with a rise in disposable income, leads to growth in the sales of menopausal products.

This menopausal hot flashes market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Menopausal Hot Flashes Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • GlaxoSmithKline Plc
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.

 

This statistical study of the menopausal hot flashes market encompasses successful business strategies deployed by the key vendors. The menopausal hot flashes market is concentrated and the vendors are deploying growth strategies such as developing new solutions and constantly increasing R&D investments to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The menopausal hot flashes market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Menopausal Hot Flashes Market?

For more insights on the market share of various regions Request for a FREE sample now!

38% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for menopausal hot flashes in North America. Market growth in this region will be faster than the growth of the market in the European and ROW regions.

The rise in awareness about menopausal symptoms and the benefits of using feminine hygiene products have resulted in an increase in demand for feminine hygiene products in North America. This will facilitate the menopausal hot flashes market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Distribution Channel Segments in the Menopausal Hot Flashes Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The menopausal hot flashes market share growth by the offline segment will be significant during the forecast period. The launch of drugs to treat menopausal symptoms combined with the growing awareness of such symptoms and their medication will consequently boost the segment by adding a greater number of offline distribution channels. There is notable growth in the number of offline distribution channels such as medical stores and others in developing and emerging economies, such as China and India, to meet the demand for medicines, owing to the presence of a massive population.

This report provides an accurate prediction of the contribution of all the segments to the growth of the menopausal hot flashes market size and actionable market insights on post COVID-19 impact on each segment.

 

Menopausal Hot Flashes Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 3.82%

Market growth 2021-2025

USD 2.19 billion

Market structure

Concentrated

YoY growth (%)

2.62

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 38%

Key consumer countries

US, UK, Germany, China, Canada, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Companies profiled

AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, GlaxoSmithKline Plc, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, and Pfizer Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Factors Covered in this Menopausal Hot Flashes Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive menopausal hot flashes market growth during the next five years
  • Precise estimation of the menopausal hot flashes market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the menopausal hot flashes industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of menopausal hot flashes market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The menopausal hot flashes market growth will increase by $727.10 million during 2019-2024.
The menopausal hot flashes market is expected to grow at a CAGR of 3.75% during 2019-2024.
Technavio has segmented the menopausal hot flashes market by distribution channel (Retail outlets and Online stores) and geographic (North America, Europe, APAC, South America, and MEA).
AbbVie Inc., Bayer AG, GlaxoSmithKline Plc, Hisamitsu Pharmaceutical Co. Inc., Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Teva Pharmaceutical Industries Ltd. are a few of the key vendors in the menopausal hot flashes market.
North America will register the highest growth rate of 36.20% among the other regions. Therefore, the menopausal hot flashes market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the menopausal hot flashes market growth are:
  • Change in lifestyle
The menopausal hot flashes market vendors should focus on grabbing business opportunities from the retail outlets segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Consumer Staples
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>